Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Net Margin (2016 - 2025)

OptimizeRx (OPRX) has disclosed Net Margin for 16 consecutive years, with 15.57% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 1581.0% to 15.57% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.69% through Dec 2025, up 2652.0% year-over-year, with the annual reading at 4.69% for FY2025, 2652.0% up from the prior year.
  • Net Margin hit 15.57% in Q4 2025 for OptimizeRx, up from 2.99% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 15.57% in Q4 2025 to a low of 49.2% in Q1 2023.
  • Historically, Net Margin has averaged 15.17% across 5 years, with a median of 13.79% in 2023.
  • Biggest five-year swings in Net Margin: tumbled -3973bps in 2023 and later surged 4581bps in 2025.
  • Year by year, Net Margin stood at 3.07% in 2021, then plummeted by -154bps to 1.66% in 2022, then crashed by -2396bps to 41.38% in 2023, then skyrocketed by 99bps to 0.24% in 2024, then surged by 6551bps to 15.57% in 2025.
  • Business Quant data shows Net Margin for OPRX at 15.57% in Q4 2025, 2.99% in Q3 2025, and 5.25% in Q2 2025.